PATENT CLAIM ANALYSIS

Application Number: 15742422
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "129000"]

Abstract:
Compounds are provided according to Formula (I) and pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof; wherein R 1 , R 2 , R 3 , R 4 , R 5 , and R 8  are as defined herein. Compounds of the present invention are contemplated useful for the prevention and treatment of a variety of conditions.

Claim (Index 69):
A method for treating or preventing a disorder comprising administering to a subject in need thereof an effective amount of a compound of  claim 1 , or a pharmaceutically acceptable salt thereof, or pharmaceutical composition thereof, wherein the disorder is a gastrointestinal (GI) disorder e.g., constipation, irritable bowel syndrome (IBS), inflammatory bowel disease (IBD) (e.g., ulcerative colitis, Crohn's disease), structural disorders affecting the GI, anal disorders (e.g., hemorrhoids, internal hemorrhoids, external hemorrhoids, anal fissures, perianal abscesses, anal fistula), colon polyps, cancer, colitis.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 86.0
- Lexical Diversity: 1.5
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15552201', '15660114', '15312614', '13993198', '15314599']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7599129953961927
- 35 USC 102 Novelty (BERT): 0.551955291335685
- Combined Prediction Score: 0.739117224990142
- Mean Citation Score: 344.124902
- Max Citation Score: 358.68613
- Similarity Product: 216.2436468489093

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test